BIRC5 and hepatocellular carcinoma: Thess GalNAc@PEG@siRNA-PLGA nanoconjugate demonstrated specific binding to ASGPRs on HCC cells which further significantly reduced the expression of survivin protein which is essential for tumor cell survival.82